세포치료 포장 시장 : 대상 치료 유형별, 포장 설계별, 사업 규모별, 주요 지역별 - 업계 동향과 세계 예측(-2035년)

Cell Therapy Packaging Market by Type of Therapy Packed, Package Engineering Design, Scale of Operation and Key Geographical Regions : Industry Trends and Global Forecasts, Till 2035

US $ 4,799 ￦ 6,584,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,603,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,542,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 24,696,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 세포치료 포장 시장 규모는 2035년까지의 예측 기간 중 11.8%의 CAGR로 확대하며, 현재 3억 6,000만 달러에서 2035년까지 12억 달러로 성장할 것으로 예측됩니다.

수년 동안 제약업계는 의약품 개발에서 몇 가지 진전을 목격해 왔으며, 한 가지 약으로 모든 것을 치료하는 모델에서 다양한 질병 적응증에 대해 개별화된 세포 치료를 사용하는 보다 맞춤 치료 접근 방식으로 점차 전환하고 있습니다. 이러한 변화는 의약품의 포장 영역에도 분명한 변화를 가져오고 있습니다. 세포치료제의 포장은 저분자 치료제나 다른 생물제제보다 상대적으로 복잡합니다. 극저온에서 세포의 무균성과 생존성을 유지하고 엄격한 품질 기준을 충족시키기 위해서는 충전, 마감, 보관, 운송에 특정 조건이 필요합니다. 세포치료제 취급의 복잡성을 고려할 때, 세포치료제 개발자는 세포치료제 포장 및 운송에 대한 전략적 계획을 수립하는 것이 필수적입니다.

최근 여러 개발자들이 세포치료제의 무균성과 품질을 보장하기 위해 업계 이해관계자들과 전략적 협약을 맺고 보관 및 운송 중 치료 개입의 무결성을 보장하기 위해 노력하고 있습니다. 서비스 프로바이더들은 이러한 새로운 첨단 치료제의 안정성을 유지하기 위해 필요한 콜드체인 및 극저온 환경에 대한 수요를 충족시키기 위해 기존 포장 제품을 넘어 포장 기술을 꾸준히 발전시키고 있다는 점은 주목할 만합니다. 세포 기반 치료제에 대한 수요가 증가함에 따라 세포치료제 포장 서비스 시장은 예측 기간 중 큰 폭의 성장이 예상됩니다.

30개 이상의 기업이 다양한 형태의 세포치료제 포장 서비스를 제공하고 있으며, 이들 기업의 대부분은 북미에 본사를 두고 있습니다. 세포치료제 포장 제품의 50% 가까이가 약품의 보관 및 보호에 사용되는 백이며, 이들 제품의 71%는 극저온 온도 범위의 포장 제품을 제공합니다. 경쟁력을 추구하기 위해 이 분야의 이해관계자들은 기존 역량을 적극적으로 업그레이드하고 포장 관련 서비스 포트폴리오를 강화하고 있습니다.

세계의 세포치료 포장 시장에 대해 조사했으며, 시장의 개요와 대상 치료 유형별, 포장 설계별, 사업 규모별, 주요 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 서문

제2장 개요

제3장 서론

제4장 세포치료 포장 서비스 프로바이더 : 시장 구도

제5장 세포치료 포장 제품 프로바이더 : 시장 구도

제6장 세포치료 포장 서비스 및 제품 프로바이더 : 기업 개요

제7장 기업 경쟁력 분석

제8장 파트너십과 협업

제9장 파트너 후보의 분석

제10장 세포치료의 개발자과 제조업체 : 사례 연구

제11장 세계의 세포치료 포장 시장

제12장 세포치료 포장 시장(대상 치료 유형별)

제13장 세포치료 포장 시장(사업 규모별)

제14장 세포치료 포장 시장(포장 설계별)

제15장 세포치료 포장 시장(주요 지역별)

제16장 결론

제17장 부록 1 : 표 형식 데이터

제18장 부록 2 : 기업·단체 리스트

KSA

영문 목차

영문목차

CELL THERAPY PACKAGING MARKET: OVERVIEW

As per Roots Analysis, the global cell therapy packaging market is estimated to grow from USD 0.36 billion in the current year to USD 1.2 billion by 2035, at a CAGR of 11.8% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Therapy Packed

• T-cell Therapies
• Dendritic Cell Vaccines
• Stem Cell Therapies
• NK-cell Therapies
• Other Advanced Therapy Medicinal Products

Scale of Operations

• Clinical Scale
• Commercial Scale

Package Engineering Design

• Primary Packaging
• Secondary Packaging

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Rest of the World

CELL THERAPY PACKAGING MARKET: GROWTH AND TRENDS

Over the years, the pharmaceutical industry has witnessed several advancements in drug development. It has gradually shifted from a one-drug treats-all model to a more personalized approach to treatment, which involves the use of personalized cell therapies for various disease indications. This shift has led to an evident change in the pharmaceutical packaging domain as well. The packaging of cell therapies is relatively more complex than that of small molecule therapeutics and other biologics. It requires specific conditions for fill / finish, storage and transportation in order to maintain the sterility and viability of cells at cryogenic temperatures and stringent quality standards. Given the complexities associated with handling cell therapies, it has become imperative for cell therapy developers to outline a strategic plan for their packaging and transportation.

In the recent past, to ensure the sterility and quality of cell therapies, several developers have forged strategic agreements with industry stakeholders to ensure the integrity of their therapeutic intervention while storage / transport. It is worth highlighting that the service providers are steadily advancing their packaging technologies beyond the conventional packaging products to meet the demand for cold chain and cryogenic environment required to maintain the stability of these novel, state-of-the-art therapies. Owing to the rising demand for cell-based therapeutics, the market for cell therapy packaging services is expected to witness substantial growth during the forecast period.

CELL THERAPY PACKAGING MARKET: KEY INSIGHTS

The report delves into the current state of the cell therapy packaging market and identifies potential growth opportunities within the industry. Some key findings from the report include:

• Several industry players claim to have the required capabilities for packaging of different types of cell therapies; of these, 94% of the firms offer multiple additional services across different stages of product development.

• Close to 90% services offered by the stakeholders in this domain are for passive packaging of cell therapies; of these, nearly 50% of the players offer dry shippers as the passive system at cryogenic temperature range.
• Over 30 companies offer packaging services for cell therapies in various formats; majority of these firms are headquartered in North America.
• Nearly, 50% of the cell therapy packaging products are bags used for storage and protection of drugs; further 71% of these products offer packaging products at cryogenic temperature ranges.
• In pursuit of a competitive edge, stakeholders in this domain are actively upgrading their existing capabilities and enhancing packaging-related service portfolios.
• Since 2016, there has been a marked increase in the partnership activity in this domain; most of the recent collaborations are focused on the packaging technology / platform integration.
• As more cell therapies are anticipated to receive approval in future, developers are anticipated to forge strategic partnerships with contract service providers to outsource a part of their business operations.
• In order to meet the rising demand for cell therapy products, manufacturers have established their presence in various regions across the world; presently, the US emerged as the key manufacturing hub for cell therapies.
• The market's growth is likely to be driven by the rising demand for cell therapies; the future opportunity to be well distributed across various scales of operation and geographies.

CELL THERAPY PACKAGING MARKET: KEY SEGMENTS

Currently, T-Cell Therapies Occupy the Largest Share of the Cell Therapy Packaging Market

Based on the type of therapy packed, the market is segmented into T-cell therapies, dendritic cell cancer vaccines, stem cell therapies, NK-cell therapies, and other advanced therapy medicinal products. Owing to their proven efficacy in treating cancer effectively, the T-cell therapies segment holds the maximum share of the cell therapy packaging market. This trend is likely to remain the same in the forthcoming years.

Commercial Scale is the Fastest Growing Segment of the Cell Therapy Packaging Market During the Forecast Period

Based on the scale of operation, the market is segmented into clinical and commercial scale. While clinical accounts for a higher market share, it is worth highlighting that the commercial scale segment is expected to witness substantial market growth in the coming years.

Currently, the Primary Packaging Segment Occupies the Largest Share of the Cell Therapy Packaging Market

Based on the package engineering designs, the market is segmented into primary and secondary packaging. At present, primary packaging holds the maximum share of the cell therapy packaging market and this trend is likely to remain the same in the forthcoming years. This can be attributed to the numerous advantages of primary packaging, such as protection, ease of use, cost-effectiveness and dosage control.

Asia-Pacific Accounts for the Largest Share of the Market

Based on the key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the world. It is worth highlighting that, over the years, the market in Europe is expected to grow at a higher CAGR.

Example Players in the Cell Therapy Packaging Market

• Advatis
• Almac
• Catalent Biologics
• Cryoport Systems
• Macopharma
• Saint-Gobain
• Technoflex
• Thermo Fisher Scientific
• West Pharmaceuticals
• Yourway

CELL THERAPY PACKAGING MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the cell therapy packaging market, focusing on key market segments, including [A] type of therapy packed, [B] scale of operation, [C] package engineering design and [D] key geographical regions.
• Market Landscape (Service Providers): A comprehensive evaluation of cell therapy packaging services providers, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of services offered, [E] type of packaging, [F] type of passive system offered, [F] packaging engineering design, [G] phase change material used.
• Market Landscape (Cell Therapy Packaging Products): A comprehensive evaluation of cell therapy packaging products, considering various parameters, such as [A] type of packaging container, [B] type of container fabrication material, [C] raw materials for container fabrication, [D] type of cells packed, [E] storage conditions, and [F] usability of container. It also includes a detailed analysis on product providers on the basis of multiple parameters, such as their [G] year of establishment, [H] company size, [I] location of headquarters and [J] most active players (in terms of number of products).
• Company Profiles: In-depth profiles of key industry players offering cell therapy packaging products and services, focusing on [A] company overviews, [B] service / product portfolio, [C] recent developments and [D] an informed future outlook.
• Company Competitiveness Analysis: A comprehensive competitive analysis of cell therapy packaging service providers, examining factors, such as [A] service strength of a company, [B] packaging portfolio and [C] service portfolio.
• Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2016, based on several parameters, such as year of partnership, type of partnership (service alliance, technology / platform integration agreement, merger and acquisition), purpose of partnership, type of service offered, and geographical location of players involved in the partnership.
• Likely Partner Analysis: A detailed evaluation of over 250 cell therapy developers that are most likely to collaborate with cell therapy packaging providers. This analysis considers various relevant parameters, including [A] developer strength (based on company size), [B] type of therapy and [C] pipeline maturity (based on stage of development of drug candidates).
• Case Study: A case study highlighting the companies that are engaged in the development and manufacturing of cell therapies, along with the information on their [A] year of establishment, [B] company size, [C] location of headquarters and [D] location of manufacturing facility. Further, the chapter includes a detailed analysis on [E] type of cells manufactured, [F] source of cells, [G] scale of operation and [H] manufacturing capabilities / services of the aforementioned companies.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• Which cell therapy developers are most likely to collaborate with service providers?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 10% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
• 1.3. Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Pharmaceutical Filling and Packaging
• 3.3. Importance of Pharmaceutical Packaging
• 3.4. Types of Pharmaceutical Packaging
• 3.5. Packaging of Cell Therapies
  • 3.5.1. Primary Packaging
  • 3.5.2. Secondary Packaging
• 3.6. Cell Therapy Packaging: Key Considerations
• 3.7. Challenges associated with Cell Therapy Packaging
• 3.8. Concluding Remarks

4. CELL THERAPY PACKAGING SERVICE PROVIDERS: MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. Cell Therapy Packaging Service Providers: Overall Market Landscape
  • 4.2.1. Analysis by Year of Establishment
  • 4.2.2. Analysis by Company Size
  • 4.2.3. Analysis by Location of Headquarters
  • 4.2.4. Analysis by Services Offered
  • 4.2.5. Analysis by Type of Packaging
  • 4.2.6. Analysis by Type of Passive System Offered
  • 4.2.7. Analysis by Type of Package Engineering Design
  • 4.2.8. Analysis by Phase Change Material Used
  • 4.2.9. Analysis by Temperature Ranges Supported
  • 4.2.10. Analysis by Type of Cells Handled

5. CELL THERAPY PACKAGING PRODUCT PROVIDERS: MARKET LANDSCAPE

• 5.1. Chapter Overview
• 5.2. Cell Therapy Packaging Products: Market Landscape
  • 5.2.1. Analysis by Type of Packaging Container
  • 5.2.2. Analysis by Container Fabrication Material and Raw Materials for Container Fabrication
  • 5.2.3. Analysis by Type of Cells Packed
  • 5.2.4. Analysis by Storage Conditions
  • 5.2.5. Analysis by Usability of Container
• 5.3. Cell Therapy Packaging: Product Providers Landscape
  • 5.3.1. Analysis by Year of Establishment
  • 5.3.2. Analysis by Company Size
  • 5.3.3. Analysis by Location of Headquarters
  • 5.3.4. Most Active Players: Distribution by Number of Products

6. CELL THERAPY PACKAGING SERVICE AND PRODUCT PROVIDERS: COMPANY PROFILES

• 6.1. Chapter Overview
• 6.2. Cell Therapy Packaging Service Providers
  • 6.2.1. Almac
    • 6.2.1.1. Company Overview
    • 6.2.1.2. Cell Therapy Service Portfolio
    • 6.2.1.3. Recent Developments and Future Outlook
  • 6.2.2. Catalent Biologics
    • 6.2.2.1. Company Overview
    • 6.2.2.2. Cell Therapy Service Portfolio
    • 6.2.2.3. Recent Developments and Future Outlook
  • 6.2.3. Cryoport Systems
    • 6.2.3.1. Company Overview
    • 6.2.3.2. Cell Therapy Service Portfolio
    • 6.2.3.3. Recent Developments and Future Outlook
  • 6.2.4. Yourway
    • 6.2.4.1. Company Overview
    • 6.2.4.2. Cell Therapy Service Portfolio
    • 6.2.4.3. Recent Developments and Future Outlook
• 6.3. Cell Therapy Packaging Product Providers
  • 6.3.1. Saint-Gobain Life Sciences
    • 6.3.1.1. Company Overview
    • 6.3.1.2. Cell Therapy Packaging Product Portfolio
    • 6.3.1.3. Recent Developments and Future Outlook
  • 6.3.2. Thermo Fisher Scientific
    • 6.3.2.1. Company Overview
    • 6.3.2.2. Cell Therapy Packaging Product Portfolio
    • 6.3.2.3. Recent Developments and Future Outlook
  • 6.3.3. West Pharmaceutical Services
    • 6.3.3.1. Company Overview
    • 6.3.3.2. Cell Therapy Packaging Product Portfolio
    • 6.3.3.3. Recent Developments and Future Outlook

7. COMPANY COMPETITIVENESS ANALYSIS

• 7.1. Chapter Overview
• 7.2. Key Parameters
• 7.3. Methodology
• 7.4. Cell Therapy Packaging Service Providers: Company Competitiveness Analysis
  • 7.4.1. Companies based in North America
  • 7.4.2. Companies based in Europe and Asia-Pacific

8. PARTNERSHIPS AND COLLABORATIONS

• 8.1. Chapter Overview
• 8.2. Partnership Models
• 8.3. Cell Therapy Packaging: List of Partnerships and Collaborations
  • 8.3.1. Analysis by Year of Partnership
  • 8.3.2. Analysis by Type of Partnership
  • 8.3.3. Analysis by Year and Type of Partnership
  • 8.3.4. Analysis by Purpose of Partnership
  • 8.3.5. Analysis by Type of Service(s) Covered
  • 8.3.6. Most Active Players: Analysis by Number of Partnerships
  • 8.3.7. Regional Analysis
  • 8.3.8. Intercontinental and Intracontinental Agreements

9. LIKELY PARTNER ANALYSIS

• 9.1. Chapter Overview
• 9.2. Scope and Methodology
• 9.3. Potential Strategic Partners for Cell Therapy Packaging Providers in North America
  • 9.3.1. Most Likely Partners
  • 9.3.2. Likely Partners
  • 9.3.3. Less Likely Partners
• 9.4. Potential Strategic Partners for Cell Therapy Packaging Providers in Europe
  • 9.4.1. Most Likely Partners
  • 9.4.2. Likely Partners
  • 9.4.3. Less Likely Partners
• 9.5. Potential Strategic Partners for Cell Therapy Packaging Providers in Asia Pacific and Rest of the World
  • 9.5.1. Most Likely Partners
  • 9.5.2. Likely Partners
  • 9.5.3. Less Likely Partners

10. CELL THERAPY DEVELOPERS AND MANUFACTURERS: CASE STUDY

• 10.1. Chapter Overview
• 10.2. Cell Therapy Manufacturers: Overall Market Landscape
  • 10.2.1. Analysis by Year of Establishment
  • 10.2.2. Analysis by Company Size
  • 10.2.3. Analysis by Location of Headquarters
  • 10.2.4. Analysis by Location of Manufacturing Facility
  • 10.2.5. Analysis by Type of Cell(s) Manufactured
  • 10.2.6. Analysis by Source of Cells
  • 10.2.7. Analysis by Scale of Operation
  • 10.2.8. Analysis by Manufacturing Capabilities / Services
  • 10.2.9. Concluding Remarks

11. GLOBAL CELL THERAPY PACKAGING MARKET

• 11.1. Chapter Overview
• 11.2. Assumptions and Methodology
• 11.3. Global Cell Therapy Packaging Services Market, Forecasted Estimates (till 2035)
• 11.4. Scenario Analysis
  • 11.4.1. Conservative Scenario
  • 11.4.2. Optimistic Scenario
• 11.5. Key Market Segmentations

12. CELL THERAPY PACKAGING MARKET, BY TYPE OF THERAPY

• 12.1. Chapter Overview
• 12.2. Key Assumptions and Methodology
• 12.3. Cell Therapy Packaging Market: Distribution by Type of Therapy
  • 12.3.1. T-cell Therapies Packaging: Forecasted Estimates (till 2035)
  • 12.3.2. Dendritic Cell Vaccines Packaging: Forecasted Estimates (till 2035)
  • 12.3.3. Stem Cell Therapies Packaging: Forecasted Estimates (till 2035)
  • 12.3.4. NK-Cell Therapies Packaging: Forecasted Estimates (till 2035)
  • 12.3.5. Other Advanced Therapy Medicinal Products Packaging: Forecasted Estimates (till 2035)
• 12.4. Data Triangulation and Validation

13. CELL THERAPY PACKAGING MARKET, BY SCALE OF OPERATION

• 13.1. Chapter Overview
• 13.2. Key Assumptions and Methodology
• 13.3. Cell Therapy Packaging Market: Distribution by Scale of Operation
  • 13.3.1. Clinical Scale: Forecasted Estimates (till 2035)
  • 13.3.2. Commercial Scale: Forecasted Estimates (till 2035)
• 13.4. Data Triangulation and Validation

14. CELL THERAPY PACKAGING MARKET, BY PACKAGE ENGINEERING DESIGN

• 14.1. Chapter Overview
• 14.2. Key Assumptions and Methodology
• 14.3. Cell Therapy Packaging Market: Distribution by Package Engineering Design
  • 14.3.1. Primary Packaging: Forecasted Estimates (till 2035)
  • 14.3.2. Secondary Packaging: Forecasted Estimates (till 2035)
• 14.4. Data Triangulation and Validation

15. CELL THERAPY PACKAGING MARKET, BY KEY GEOGRAPHICAL REGIONS

• 15.1. Chapter Overview
• 15.2. Key Assumptions and Methodology
• 15.3. Cell Therapy Packaging Market: Distribution by Key Geographical Regions
  • 15.3.1. North America: Forecasted Estimates (till 2035)
  • 15.3.2. Europe: Forecasted Estimates (till 2035)
  • 15.3.3. Asia-Pacific: Forecasted Estimates (till 2035)
  • 15.3.4. Rest of the World: Forecasted Estimates (till 2035)
• 15.4. Data Triangulation and Validation

16. CONCLUDING REMARKS

• 16.1. Chapter Overview

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

관련자료